Law360, New York (August 16, 2011, 4:45 PM ET) -- Nycomed US Inc. and Medicis Pharmaceutical Corp. on Tuesday reached a licensing agreement to settle a patent infringement fight in New York over a generic version of skin treatment Vanos.
U.S. District Judge Denise L. Cote dismissed the suit after the two pharmaceutical companies notified the court that they had agreed on a licensing agreement. Melville, N.Y.-based Nycomed, which had been accused of violating three patents, acknowledged that its abbreviated new drug application for a generic Vanos would infringe on Medicis' patents if not for the...
Medicis, Nycomed Settle Vanos Patent Dispute
To view the full article, take a free trial now.
